Integrated cannabinoid synthesis suitable for long-term needs

Challenges of plant-based Cannabis production, including the large footprint of greenhouses or exterior fields, use of pesticides and fertilizers, security requirements and inconsistent levels of the active compounds, make the synthetic approach of cannabinoid manufacturing a better longer-term strategy for pharmaceutical development and supply. The current traditional method to obtain cannabinoids – plant, grow, harvest, extract and purify – is not feasible for long-term pharmaceutical demand.

A synthetic process provides for a reliable, consistent, scalable and compliant process versus the variability and complexity associated with the extraction and purification of the cannabinoids directly from the plant.

As interest in the therapeutic potential of cannabinoids continues to grow, IntegraSynTM may be the solution to provide access to a range of cost-effective, bio-identical cannabinoids.